Another Cannabis Pioneer Expands In Germany Via Acquisition As Experts Say ‘There’s No Stepping Back’ From Legalization Wave

Flora Growth Corp. (NASDAQ:FLGC) has entered into a definitive agreement to acquire all of the issued and outstanding shares of Germany-based TruHC Pharma GmbH.

The company’s latest move to further cement its global footprint comes on the heels of a new German cannabis law that went into effect on April 1, which partially legalizes cannabis by allowing adults over 18 to possess up to 25 grams of dried cannabis and grow three marijuana plants at home.

Flora Growth, through its wholly-owned subsidiaries, has been active in Germany since 2017. Other companies, like Aurora Cannabis, Inc (NASDAQ:ACB) (TSX:ACB), Tilray Brands, Inc. (NASDAQ:TLRY) and Curaleaf Holdings Inc. (CSE:CURA) (OTCQX:CURLF) also ventured into the new market. Dr. Constantin von der Groeben, a managing director of Demecan – the only German vertically integrated medicinal cannabis company – told the crowd gathered at the Benzinga Cannabis Capital …

Full story available on Benzinga.com